CO5690560A2 - Compuestos derivados de dibenzo-azepin y benzoazepin sustituidos inhibidores de gamma secretasa, su proceso de sintesis y composiciones farmaceuticas que los contienen - Google Patents
Compuestos derivados de dibenzo-azepin y benzoazepin sustituidos inhibidores de gamma secretasa, su proceso de sintesis y composiciones farmaceuticas que los contienenInfo
- Publication number
- CO5690560A2 CO5690560A2 CO06034536A CO06034536A CO5690560A2 CO 5690560 A2 CO5690560 A2 CO 5690560A2 CO 06034536 A CO06034536 A CO 06034536A CO 06034536 A CO06034536 A CO 06034536A CO 5690560 A2 CO5690560 A2 CO 5690560A2
- Authority
- CO
- Colombia
- Prior art keywords
- lower alkyl
- hydrogen
- cycloalkyl
- secretasa
- benzoazepin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Compuestos de fórmula general en donde R1 es -(CHR´)q-arilo o -(CHR´)q-heteroarilo, que están sin sustituir o mono, di- o tri-sustituidos por alquilo inferior, alcoxilo inferior, CF3 o halógeno, o es alquilo inferior, alquenilo inferior, -(CH2)n-Si(CH3)3, -(CH2)n-O-alquilo inferior, -(CH2)n-S-alquilo inferior, -(CH2)q-cicloalquilo, -(CH2)n[CH(OH)]m-(CF2)p-CHqF(3-q), o es -(CH2)n-CR2-CF3, en donde los dos radicales R forman junto con el átomo de carbono un anillo cicloalquilo;R´ es hidrógeno o alquilo inferior;n es 1, 2 ó 3;m es 0 ó 1;p es 0, 1, 2, 3, 4, 5 ó 6;q es 0, 1, 2 ó 3;R2 es hidrógeno o alquilo inferior;R3 es hidrógeno, alquilo inferior, -CH2CF2CF3, CH2CF3, (CH2)2CF3, CF3, CHF2, CH2F o es arilo, opcionalmente mono, di o tri-sustituidos por halógeno, o es -(CH2)nNR5R6, en donde R5 y R6 son independientemente el uno del otro hidrógeno o alquilo inferior;R4 es uno de los siguientes grupos en donde R7 es hidrógeno, alquilo inferior, -(CH2)n-CF3 o -(CH2)n-cicloalquilo;R8 es hidrógeno, alquilo inferior, -C(O)-fenilo, -C(O)-alquilo inferior, -C(O)O-(CH2)n-cicloalquilo, -C(O)O-(CH2)n-alquilo inferior, -C(O)NH-(CH2)n-alquilo inferior o -C(O)NH-(CH2)n-cicloalquilo;R9 es hidrógeno, alquilo inferior, -(CH2)n-cicloalquilo o -(CH2)n-CF3;y a sales de adición ácida farmacéuticamente aceptables, enantiómeros ópticamente puros, racematos o mezclas diastereoméricas de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03022650 | 2003-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5690560A2 true CO5690560A2 (es) | 2006-10-31 |
Family
ID=34384575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO06034536A CO5690560A2 (es) | 2003-10-06 | 2006-04-07 | Compuestos derivados de dibenzo-azepin y benzoazepin sustituidos inhibidores de gamma secretasa, su proceso de sintesis y composiciones farmaceuticas que los contienen |
Country Status (27)
Country | Link |
---|---|
US (1) | US7166587B2 (es) |
EP (1) | EP1673347B1 (es) |
JP (1) | JP4503607B2 (es) |
KR (2) | KR100884872B1 (es) |
CN (1) | CN1894217B (es) |
AR (1) | AR045859A1 (es) |
AU (1) | AU2004283803B2 (es) |
BR (1) | BRPI0415070B8 (es) |
CA (1) | CA2541470C (es) |
CO (1) | CO5690560A2 (es) |
CY (1) | CY1116865T1 (es) |
DK (1) | DK1673347T3 (es) |
ES (1) | ES2548720T3 (es) |
HR (1) | HRP20151197T1 (es) |
HU (1) | HUE025548T2 (es) |
IL (1) | IL174513A (es) |
MX (1) | MXPA06003870A (es) |
MY (1) | MY143797A (es) |
NO (1) | NO20061469L (es) |
NZ (1) | NZ546036A (es) |
PL (1) | PL1673347T3 (es) |
PT (1) | PT1673347E (es) |
RU (1) | RU2356895C2 (es) |
SI (1) | SI1673347T1 (es) |
TW (1) | TWI293627B (es) |
WO (1) | WO2005040126A1 (es) |
ZA (1) | ZA200602802B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
US7211573B2 (en) | 2004-12-08 | 2007-05-01 | Hoffmann-La Roche Inc. | Malonamide derivatives |
EP1942101A4 (en) * | 2005-09-05 | 2010-08-25 | Yoshiaki Kiso | INHIBITOR OF -SECRETASE |
RU2440342C2 (ru) * | 2006-03-27 | 2012-01-20 | Ф.Хоффманн-Ля Рош Аг | МАЛОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ γ-СЕКРЕТАЗЫ |
BRPI0717587A2 (pt) | 2006-09-20 | 2013-10-29 | Hoffmann La Roche | Derivados de 4-oxo-2,3,4,5-tetra-hidro-benzo[b][1,4]diazepina |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
MX2009007864A (es) | 2007-02-02 | 2009-07-31 | Hoffmann La Roche | Derivados de 6-oxo-6,7-dihidro-5h-dibenzo[b,d]azepin-7-ilo. |
AU2008220785B2 (en) | 2007-03-01 | 2013-02-21 | Vivoryon Therapeutics N.V. | New use of glutaminyl cyclase inhibitors |
FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
US7579464B2 (en) * | 2007-05-25 | 2009-08-25 | Hoffmann-La Roche Inc. | Process for preparation of enantiomerically pure compounds |
PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
US20130102538A1 (en) * | 2010-05-05 | 2013-04-25 | Amicus Therapeutics, Inc. | Method of treating alzheimer's disease using pharmacological chaperones to increase presenilin function and gamma-secretase activity |
EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
AR087107A1 (es) | 2011-07-27 | 2014-02-12 | Lilly Co Eli | Compuesto inhibidor de la señalizacion de la trayectoria notch |
ES2751082T3 (es) * | 2015-10-30 | 2020-03-30 | Pipeline Therapeutics Inc | Compuestos de dibenzo azepina y su uso en el tratamiento de enfermedades y trastornos óticos |
RU2757276C2 (ru) * | 2016-12-16 | 2021-10-12 | Пайплайн Терапьютикс, Инк. | Способы лечения кохлеарной синаптопатии |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
AU2019271151A1 (en) * | 2018-05-15 | 2021-01-07 | Ayala Pharmaceuticals Inc. | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2347671A1 (en) * | 1998-12-24 | 2000-07-06 | Dupont Pharmaceuticals Company | Succinoylamino benzodiazepines as inhibitors of a.beta. protein production |
US6632812B2 (en) * | 2000-04-11 | 2003-10-14 | Dupont Pharmaceuticals Company | Substituted lactams as inhibitors of Aβ protein production |
AU783857B2 (en) * | 2000-06-01 | 2005-12-15 | Bristol-Myers Squibb Pharma Company | Lactams substituted by cyclic succinates as inhibitors of a beta protein production |
CA2514267C (en) * | 2003-02-04 | 2011-05-17 | F. Hoffmann-La Roche Ag | Malonamide derivatives as gamma-secretase inhibitors |
SI1711470T1 (sl) * | 2003-09-09 | 2009-08-31 | Hoffmann La Roche | Derivati malonamida, ki blokirajo aktivnost gama-sekretaze |
-
2004
- 2004-09-27 CN CN2004800333748A patent/CN1894217B/zh active Active
- 2004-09-27 JP JP2006530028A patent/JP4503607B2/ja active Active
- 2004-09-27 ES ES04787028.2T patent/ES2548720T3/es active Active
- 2004-09-27 PL PL04787028T patent/PL1673347T3/pl unknown
- 2004-09-27 EP EP04787028.2A patent/EP1673347B1/en active Active
- 2004-09-27 MX MXPA06003870A patent/MXPA06003870A/es active IP Right Grant
- 2004-09-27 US US10/951,229 patent/US7166587B2/en active Active
- 2004-09-27 SI SI200432267T patent/SI1673347T1/sl unknown
- 2004-09-27 RU RU2006115165/04A patent/RU2356895C2/ru not_active IP Right Cessation
- 2004-09-27 HU HUE04787028A patent/HUE025548T2/en unknown
- 2004-09-27 CA CA2541470A patent/CA2541470C/en active Active
- 2004-09-27 KR KR1020087003016A patent/KR100884872B1/ko active IP Right Grant
- 2004-09-27 PT PT47870282T patent/PT1673347E/pt unknown
- 2004-09-27 NZ NZ546036A patent/NZ546036A/en unknown
- 2004-09-27 WO PCT/EP2004/010821 patent/WO2005040126A1/en active Application Filing
- 2004-09-27 KR KR1020067006540A patent/KR100867035B1/ko active IP Right Grant
- 2004-09-27 BR BRPI0415070A patent/BRPI0415070B8/pt active IP Right Grant
- 2004-09-27 AU AU2004283803A patent/AU2004283803B2/en active Active
- 2004-09-27 DK DK04787028.2T patent/DK1673347T3/en active
- 2004-10-04 TW TW093130014A patent/TWI293627B/zh active
- 2004-10-04 AR ARP040103592A patent/AR045859A1/es unknown
- 2004-10-05 MY MYPI20044077A patent/MY143797A/en unknown
-
2006
- 2006-03-23 IL IL174513A patent/IL174513A/en active IP Right Grant
- 2006-03-31 NO NO20061469A patent/NO20061469L/no not_active Application Discontinuation
- 2006-04-05 ZA ZA200602802A patent/ZA200602802B/en unknown
- 2006-04-07 CO CO06034536A patent/CO5690560A2/es not_active Application Discontinuation
-
2015
- 2015-10-29 CY CY20151100963T patent/CY1116865T1/el unknown
- 2015-11-09 HR HRP20151197TT patent/HRP20151197T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5690560A2 (es) | Compuestos derivados de dibenzo-azepin y benzoazepin sustituidos inhibidores de gamma secretasa, su proceso de sintesis y composiciones farmaceuticas que los contienen | |
PE20090042A1 (es) | Analogos de ciclopamina | |
ECSP066414A (es) | Derivados de malonamida que bloquean la actividad de gama-secretasa | |
AR050435A1 (es) | DERIVADOS DE HIDROXIAMIDA, PROCESOS DE OBTENCIoN Y COMPOSICIONES FARMACÉUTICAS. | |
PE20090159A1 (es) | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs | |
EA200701640A1 (ru) | Новые соединения с терапевтическим эффектом | |
AR047823A1 (es) | Derivados de 1,2,3,4-tetrahidroisoquinolina sustituida | |
AR062666A1 (es) | Benzotriazoles como moduladores de quinasas | |
AR042691A1 (es) | Agonistas inversos del receptor cb1 procedimientos de obtencion y composiciones farmaceuticas. | |
MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
AR055053A1 (es) | Compuestos indol sustituidos con actividad inhibidora de nos. composiciones farmaceuticas. | |
AR091498A1 (es) | DERIVADOS DE 2,3-DIHIDRO-1H-IMIDAZO{1,2-a}PIRIMIDIN-5-ONA Y 1,2,3,4-TETRAHIDRO-PIRIMIDO{1,2-a}PIRIMIDIN-6-ONA QUE CONTIENEN UNA MORFOLINA SUSTITUIDA, SU PREPARACION Y SU UTILIZACION FARMACEUTICA | |
PE20141075A1 (es) | 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina | |
CO6270228A2 (es) | Derivados de quinazilinona 6-, 7-, u 8 -sustituidos y composiciones que los comprenden y metodos para usar los mismos | |
AR064730A1 (es) | Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk | |
EA200600364A1 (ru) | Производные (тио)карбамоилциклогексана в качестве антагонистов d/dрецептора | |
AR085088A1 (es) | Inhibidores de histona desacetilasa y composiciones farmaceuticas que los contienen | |
ES2531315T3 (es) | Compuestos de fosfinato antivíricos | |
AR054482A1 (es) | Derivados de azetidinona para el tratamiento de hiperlipidemias | |
PE20060583A1 (es) | Tiazolil-dihidro-indazoles como inhibidores de pi3-quinasas | |
AR041855A1 (es) | 4 amino-1- (piridilmetil) piperidina sustituida y compuestos relacionados | |
AR068912A1 (es) | Derivados de 6- aril/ heteroarilquiloxi benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y utilizacion como inhibidores de cmet | |
AR044400A1 (es) | Procesos para la preparacion de derivados de pirimidina | |
PH12019550083A1 (en) | Inhibitors of bruton's tyrosine kinase | |
AR054766A1 (es) | Amidas derivadas de acidos piperidin carboxilicos y su uso como ingredientes activos en la preparacion de composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted | ||
FD | Application lapsed |